Navigation Links
New Treatment Offers Hope for Systemic Sclerosis

Systemic sclerosis (SSc) is a chronic autoimmune disorder marked by early skin lesions and the progressive tissue fibrosis.// More than skin deep, this thickening and hardening of connective tissue affects the blood capillaries, the gastrointestinal tract, the lungs, and the heart. In SSc patients, fibrosis frequently leads to organ dysfunction, serious illness, and death. Researchers have yet to determine the underlying cause of this disfiguring, debilitating condition or find an effective anti-fibrotic remedy.

Studies of SSc suggest the central role of two cytokines, transforming growth factor ? (TGF?) and platelet-derived growth factor (PDGF), in the development of fibrosis through stimulating the synthesis of extracellular matrix (ECM) proteins. On the strength of these findings, researchers at the University of Erlangen-Nuremberg, Germany and University Hospital Zurich, Switzerland, set out to test the therapeutic potential for SSc patients of a small growth factor inhibiting molecule widely used in the treatment of leukemia.

Through skin biopsies, researchers obtained fibroblast cultures from the lesions of five patients with SSc, and six healthy sex- and age-matched controls. All the specimens were stimulated with TGF? and PDGF and incubated with the inhibitory molecule, imatinib mesylate. Then, applying real-time polymerase chain reaction and various assays, researchers analyzed and compared the expression of EMC proteins in SSc and normal skin fibroblasts. In addition, they assessed the anti-fibrotic effects of imatinib mesylate on laboratory mice with bleomycin-induced dermal fibrosis compared with non-diseased controls.

On the experimental fibroblast cultures from SSc patients, imatinib mesylate strongly reduced the synthesis of EMC proteins, the number of myofibroblasts, and the thickness of skin, almost back to levels observed in the healthy control groups. Similarly, imatinib mesylate effectively suppressed the deve
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:7/8/2008)... SKINTASTIC™ is p...ed Evolence®--the latest injectable collagen f...owntime beauty treatments. EVOLENCE® utilizes ...as a preferred medical grafting substance due to i... , N. Dallas/Plano, TX (PR...
(Date:7/8/2008)... HARRISBURG, Pa., July 8 /PRNewswire-USNewswire...ecutive order regarding the Pennsylvania Health,Ca...fter the law,authorizing its operation expired on ...hen PHC4 was allowed to "sunset",by the General As...ction., The Rendell administration is committed t...
(Date:7/8/2008)...,This new executive team will give the men we serv..., said Carl J. Bentley, President, M.I. Board of ...July 8 /PRNewswire/ -- The Mariners Inn shelter an...ng the appointment of Jim Hartz as,chief executive...cer., "Both Jim and David are outstanding leaders...
(Date:7/8/2008)... Reductions in Iron Blood Levels Associated with...rial Disease , Men with peripheral arterial dis...rial in which their iron stores were reduced by bl...tive to men in the trial who did not undergo blood... that lower levels of iron in the blood may be ass...
Breaking Medicine News(10 mins):Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 3Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 2Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 3Health News:Mariners Inn Announces New Executive Leadership 2Health News:Also in the July 8 JNCI 2Health News:Also in the July 8 JNCI 3Health News:Also in the July 8 JNCI 4
...enue, Newcastle-under-Lyme, Staffordshire, was cha...gs died shortly after birth at a Shropshire hospit...essive force. The doctor said that he used a sucti...as not in the right position. A Birmingham Crown ...
...formed testicular cells obtained from male mice in...cks that have the remarkable ability to transform ...elief the same could be achieved in humans, helpin...ated with the derivation of embryonic stem cells f...
...st two times since 1990 in America. Labor, deliver..., are now being increasingly manipulated to suit t... A pregnant Super Bowl fan in Pittsburg told news ...for an early labor induction so that she would not...
...clinical psychologist and author, a lot of woman p...vereater’s who try to mask their depression with f... generally do not seek treatment for their depress...unity and family members don't recognize depressio...
Other Medicine News:Health News:To Wait Or Not 2Health News:African-American Women Need To Seek Advice On depression 2
(Date:7/7/2008)... ATLANTA, July 7 /- GeoV...ta based, publicly traded biopharmaceutical,compan...infectious,diseases, today provided an operational... Phase 2 preventative human clinical trial testing...s with its AIDS vaccine. Five,successful human tri...
(Date:7/7/2008)... CAMBRIDGE, Mass., July 7 /PRNewswire-FirstCall...d today that it has had discussions with the Food,...ceptable patient,population for a new clinical tri...ne)], or HBOC-201. Biopure has proposed to study u...elogenous Leukemia (AML) who refuse,transfusion wi...
(Date:7/7/2008)... New Study Suggests Kiwifruit is Top Perfo... Not all fruits are created equal when,it comes to...s among the,highest in bioavailability compared to...cent small-scale study published in the Journal of... include vitamins and phytochemicals called flavon...
(Date:7/6/2008)... Results are basis for CTI,s Marketing Authorizati...der review by the EMEA, SEATTLE, July 7 /PRNewswi...sdaq: CTIC ; MTA) today announced the publication...mparing OPAXIO(TM) (paclitaxel poliglumex,CT-2103...t of PS 2,(performance status 2) patients with pre...
Breaking Medicine Technology:GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Kiwifruit: Antioxidant Power in Quantity and Quality 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5A study proposes a new universal rule to explain the equilibrium of plant populations 433 1A study proposes a new universal rule to explain the equilibrium of plant populations 433 2Old at Age 3 3A The Inspiring Life of Progeria Patient Zachary Moore 1460 1Old at Age 3 3A The Inspiring Life of Progeria Patient Zachary Moore 1460 2Old at Age 3 3A The Inspiring Life of Progeria Patient Zachary Moore 1460 3Old at Age 3 3A The Inspiring Life of Progeria Patient Zachary Moore 1460 4GlaxoSmithKline Awarded U S Department of Defense Contract to Pursue Novel Antibacterial Research Program 645 1GlaxoSmithKline Awarded U S Department of Defense Contract to Pursue Novel Antibacterial Research Program 645 2GlaxoSmithKline Awarded U S Department of Defense Contract to Pursue Novel Antibacterial Research Program 645 3Premier Research Appoints Global Head of Human Resources 642 1Premier Research Appoints Global Head of Human Resources 642 2
...IRE)--May 22, 2007 - Medtronic,(NYSE:MDT) today pr...cal trial program reinforcing the existing safety ...ng coronary stent system.,Four-year results from t...hree-year results from the nearly 1,200 patient EN...iated with sustained,safety, significant reduction...
...ox Maintained Stability,Significantly Longer than ...le Comparable with Placebo , MARIETTA, Ga. and COL...als, Inc., Wyeth Pharmaceuticals, a division of Wy...l study results on,bifeprunox, an investigational ...phrenia, today at the 2007 annual meeting of,the A...
Other Medicine Technology:Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing,Sustained Safety and Significant Reductions in Repeat Procedures 2Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing,Sustained Safety and Significant Reductions in Repeat Procedures 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: